Table 6.
Outcomes of the metrics with P values of statistical tests
| All | Oncological | Non-oncological | Significant difference? | P value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | 100.0 | (140/140) | 42.9 | (60/140) | 57.1 | (80/140) | ||||||
| CI—Mention/Specialization | 40.7 | (57/140) | 58.3 | (35/60) | 27.5 | (22/80) | Yesb | 0.0005a | ||||
| CI—Generalization | 16.4 | (23/140) | 30.0 | (18/60) | 6.3 | (5/80) | Yesb | 0.0004a | ||||
| CI—Common comorbidity | 6.4 | (9/140) | 3.3 | (2/60) | 8.8 | (7/80) | Nob | 0.3446a | ||||
| CI—No mention | 36.4 | (51/140) | 8.3 | (5/60) | 57.5 | (46/80) | Yesb | <0.0001a | ||||
| Hx—Mention/Specialization | 62.1 | (87/140) | 83.3 | (50/60) | 46.3 | (37/80) | Yesb | <0.0001a | ||||
| Hx—Generalization | 7.1 | (10/140) | 13.3 | (8/60) | 2.5 | (2/80) | Yesb | 0.0330a | ||||
| Hx—Common comorbidity | 6.4 | (9/140) | 1.7 | (1/60) | 10.0 | (8/80) | Nob | 0.1007a | ||||
| Hx—No mention | 24.3 | (34/140) | 1.7 | (1/60) | 41.3 | (33/80) | Yesb | <0.0001a | ||||
| No documented evidence | 24.0 | (33/140) | 0.0 | (0/60) | 41.3 | (33/80) | Yesb | <0.0001a | ||||
| Improvement rate | 46.0 | (38/83) | 80.0 | (20/25) | 31.0 | (18/58) | Yesb | 0.0001a | ||||
| Refinement rate | 63.0 | (20/32) | 75.0 | (15/20) | 41.7 | (5/12) | Nob | 0.1314a | ||||
| Treasure hunt rate | 35.0 | (18/51) | 100.0 | (5/5) | 28.3 | (13/46) | Yesb | 0.0070a | ||||
| Stat | Regular | Significant difference? | P value | ICD-9 only | ICD-9 and manual | Significant difference? | P value | |||||
| N | 17.9 | (25/140) | 82.1 | (115/140) | 39.3 | (55/140) | 60.7 | (85/140) | ||||
| CI—Mention/Specialization | 36.0 | (9/25) | 41.7 | (48/115) | Nob | 0.7605a | 20.0 | (11/55) | 54.1 | (46/85) | Yesb | 0.0001a |
| CI—Generalization | 0.0 | (0/25) | 20.0 | (23/115) | Yesb | 0.0317a | 30.9 | (17/55) | 7.1 | (6/85) | Yesb | 0.0005a |
| CI—Common comorbidity | 4.0 | (1/25) | 7.0 | (8/115) | Nob | 0.9232a | 9.1 | (5/55) | 4.7 | (4/85) | Nob | 0.4963a |
| CI—No mention | 60.0 | (15/25) | 31.3 | (36/115) | Yesb | 0.0134a | 40.0 | (22/55) | 34.1 | (29/85) | Nob | 0.5985a |
| Hx—Mention/Specialization | 52.0 | (13/25) | 64.3 | (74/115) | Yesb | 0.0045a | 69.1 | (38/55) | 57.6 | (49/85) | Nob | 0.2360a |
| Hx—Generalization | 0.0 | (0/25) | 8.7 | (10/115) | Nob | 0.2706a | 5.5 | (3/55) | 8.2 | (7/85) | Nob | 0.7734a |
| Hx—Common comorbidity | 0.0 | (0/25) | 7.8 | (9/115) | Nob | 0.3192a | 7.3 | (4/55) | 5.9 | (5/85) | Nob | 0.9799a |
| Hx—No mention | 48.0 | (12/25) | 19.1 | (22/115) | Yesb | 0.0052a | 18.2 | (10/55) | 28.2 | (24/85) | Nob | 0.2489a |
| No documented evidence | 48.0 | (12/25) | 18.3 | (21/115) | Yesb | 0.0035a | 18.2 | (10/55) | 27.1 | (23/85) | Nob | 0.3150a |
| Improvement rate | 25.0 | (4/16) | 50.7 | (34/67) | Nob | 0.1146a | 65.9 | (29/44) | 23.1 | (9/39) | Yesb | 0.0002a |
| Refinement rate | 100.0 | (1/1) | 61.3 | (19/31) | Nob | 1.0000a | 77.3 | (17/22) | 30.0 | (3/10) | Yesb | 0.0303a |
| Treasure hunt rate | 20.0 | (3/15) | 41.7 | (15/36) | Nob | 0.2486a | 54.5 | (12/22) | 20.7 | (6/29) | Yesb | 0.0271a |
aChi-squared test result not reliable
bSignificant with respect to Bonferonni-adjusted α = 0.001388889 (0.05 / [3 × 12])